Are Costs Decisive in the Incorporation of Medicines for the Treatment of Ultra-Rare Diseases in Brazil? Trends in Healthcare Coverage for Ultra-Rare Diseases

被引：0

作者：

Lopes, Luciane Cruz ^{[1
]}

Pereira Curado, Daniel da Silva ^{[2
]}

Machado-Rugolo, Juliana ^{[1
]}

de Paula de Sordi, Monica Aparecida ^{[3
]}

Komoda, Denis Satoshi ^{[4
]}

Modelli de Andrade, Luis Gustavo ^{[5
]}

Theresa Weber, Silke Anna ^{[6
]}

Tarride, Jean Eric ^{[7
]}

Thabane, Lehana ^{[7
]}

Santos, Marisa ^{[8
]}

de Almeida Cardoso, Marilia Mastrocolla ^{[3
]}

机构：

[1] Univ Sorocaba, Pharmaceut Sci Grad Course, Sorocaba, SP, Brazil

[2] Minist Hlth, Brasilia, DF, Brazil

[3] Hosp Clin Fac Med Botucatu HCFMB, Hlth Technol Assessment, Botucatu, SP, Brazil

[4] Univ Estadual Campinas, Campinas, SP, Brazil

[5] Hosp Clin Fac Med Botucatu HCFMB, Lab Data Sci & Predict Anal Hlth, Botucatu, SP, Brazil

[6] Sao Paulo State Univ Unesp, Botucatu Med Sch FMB, Botucatu, SP, Brazil

[7] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada

[8] Natl Inst Cardiol, Rio De Janeiro, RJ, Brazil

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

1488

引用

页码：673 / 674

页数：2

共 50 条

[21] NINDS launches network to develop treatments for ultra-rare neurological diseases
Schor, Nina F.
Tamiz, Amir P.
Koroshetz, Walter J.
Broome, Ann-Marie
Bachman, Julia L.
Boshoff, Chris
Cordell, Janice
Dhruv, Neel T.
Gubitz, Amelie
Hartman, Adam L.
Koroshetz, Walter J.
Lind, Genevieve E.
Lungu, Codrin I.
Morris, Jill A.
Nuckolls, Glen H.
Rajaram, Shantadurga
Rangarajan, Ranga
Roof, Rebecca A.
Schor, Nina F.
Skiadopoulos, Mario H.
Strunnikova, Natalia
Tamiz, Amir P.
Wong, Ling M.
Wright, Clinton B.
NATURE BIOTECHNOLOGY, 2021, 39 (12) : 1497 - 1499
[22] The AI-Led Engine Advancing Our Understanding of Rare and Ultra-Rare Diseases
Genetic Engineering and Biotechnology News, 2022, 42 (09):
[23] NAVIGATING RWE STRATEGIES IN HTA SUBMISSIONS FOR ULTRA-RARE DISEASES IN KEY EUROPEAN HEALTHCARE SYSTEMS
Proshenska, D.
Demian, E.
Net, P.
Kumar, P.
VALUE IN HEALTH, 2024, 27 (12)
[24] Care for patients with ultra-rare disorders
Hennekam, Raoul C. M.
EUROPEAN JOURNAL OF MEDICAL GENETICS, 2011, 54 (03) : 220 - 224
[25] Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR
Richter, Trevor
Janoudi, Ghayath
Amegatse, William
Nester-Parr, Sandra
ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
[26] Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR
Trevor Richter
Ghayath Janoudi
William Amegatse
Sandra Nester-Parr
Orphanet Journal of Rare Diseases, 13
[27] Ultra-rare disease: an European perspective
Harari, Sergio
Humbert, Marc
EUROPEAN RESPIRATORY REVIEW, 2020, 29 (156):
[28] The Genetics of Ultra-Rare Renal Disease
Muff-Luett, Melissa
Nester, Carla M.
JOURNAL OF PEDIATRIC GENETICS, 2016, 5 (01) : 33 - 42
[29] TOO ULTRA-RARE FOR CARE? ORPHAN DRUG AVAILABILITY FOR RESPIRATORY DISEASES: A SYSTEMATIC REVIEW
Matthews, H.
Lovelace, M.
Freitag, A.
Iheanacho, I.
VALUE IN HEALTH, 2019, 22 : S857 - S857
[30] ASSESSING THE RELATIONSHIP BETWEEN LIFELONG VALUE AND PRICING FOR ORPHAN DRUGS IN ULTRA-RARE DISEASES
Dabbous, O.
Zhou, Z. Y.
Tang, C.
Harvey, M.
Wu, E. Q.
Arjunji, R.
VALUE IN HEALTH, 2019, 22 : S388 - S388

← 1 2 3 4 5 →